Last reviewed · How we verify

NCT07442201: CPSV

Intraoperative Carotid Peak Systolic Velocity Variability in Liver Transplant Patients

Completed Last updated 2 March 2026
What this trial tests

trial in Liver Transplant Disorder in 42 participants. Completed in 10 January 2025.

Timeline
18 September 2023
Primary endpoint
29 April 2024
10 January 2025

Quick facts

Lead sponsorInonu University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment42
Start date18 September 2023
Primary completion29 April 2024
Estimated completion10 January 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Inonu University

Who can join

Adults 18 to 65, any sex, with Liver Transplant Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate carotid peak systolic velocity variability using intraoperative ultrasound and to determine whether this method is useful in the assessment of hemodynamic status and intravascular volume in liver transplantation. Previously, a similar study was performed in liver transplant intensive care unit, but no study was performed to evaluate intraperative fluid status with carotid ultrasonography.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Liver Transplant Disorder

Currently open trials in the same condition.

Other Inonu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07442201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing